Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...

Smallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 ear...

Wockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performanc...

Wockhardt extended its winning streak for the third straight session, drawing strong investor interest with trading volumes surging over 4....

The Mumbai-based drug maker reported a net loss of Rs 136 crore in Q1FY25. Revenue rose 14% year-on-year (y-o-y) to Rs.747 crore in Q1FY25 ...

Drug firm Wockhardt on Tuesday reported a consolidated net loss of Rs 177 crore for the fourth quarter ended March 31, 2024. The company ha...

Wockhardt had agreed to pay $36 million and interest over nine installments between 2022 and 2025 to the State of Texas in a drug pricing c...

The consolidated total income of the company for the quarter under consideration stood at Rs 639.50 crore. It was Rs 700.66 crore for the s...

Consolidated revenue from operations for the recently concluded fiscal year stood at Rs 4,158.38 crore.

Consolidated revenue from operations for the recently concluded fiscal year stood at Rs 4,158.38 crore.

At present, Khorakiwala himself is engaged in negotiations with a clutch of PE funds.

The company had posted a net loss of Rs 174.72 crore last year.

Wockhardt Ltd surged over 4% in trade to hit its 52-week high of Rs 1784.90 on Thursday after the drug firm said its consolidated net profi...

Shares of Wockhardt surged over 6 per cent to hits its 52-week high of Rs 1084.60 after the company announced strong quarterly results.

Mumbai based Wockhardt Pharma's stock price soared by 7 % at Rs 715 as the company beat the street estimates and posted a healthy Q4 margin...

It was a roller-coaster ride for traders betting on Wockhardt shares on the day the company declared its Q4 results.

Wockhardt has clocked a net loss of Rs 565.2 crore during Q4 FY10 compared to a net loss of Rs 10.2 crore during the corresponding period o...